Concerned that improperly managed financial conflicts of interest from industry-sponsored biomedical research may be damaging the credibility of scientists and their institutions, the Federation of American Societies for Experimental Biology (FASEB) will today (July 17) urge adoption of voluntary nationwide guidelines to manage these relationships. FASEB will meet today with representatives from academic and professional research societies to discuss a set of preliminary guidelines and practices, derived from 19 separate rules FASEB published in July 2006. The goal of the meeting is to get feedback on the proposed practices, which include not working with companies that seek to delay or prohibit publication of research results and making sure all financial interests are fully disclosed. Eventually, FASEB plans to unveil a web-based conflict of interest toolkit to give scientists, university managers, industry sponsors, scientific societies, and journal publishers access to recommended practices. "Our call is to set up common, uniform policies...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?